ArticleHemaSphere2025

Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy.

Jort J van der Schans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.